A national cancer institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers
暂无分享,去创建一个
P C Prorok | P. Prorok | B. Kramer | C. Smart | John F. Gohagan | B S Kramer | J Gohagan | C Smart
[1] V. Zurawski,et al. Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: Relevance for early detection of ovarian cancer , 1988, International journal of cancer.
[2] M. Young,et al. Accuracy of pelvic examination. , 1991, Annals of internal medicine.
[3] Ja Wilson,et al. Principles and practice of screening for disease , 1968 .
[4] S. Ellenberg,et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials , 1990, The New England journal of medicine.
[5] T. Bourne,et al. Ovarian cancer screening. , 1991, European journal of cancer.
[6] R. Bast,et al. The CA 125 tumour-associated antigen: a review of the literature. , 1989, Human reproduction.
[7] S. Bates,et al. Clinical applications of serum tumor markers. , 1991, Annals of Internal Medicine.
[8] A. Stenwig,et al. Prognostic Factors in Patients With Stage I Epithelial Ovarian Cancer , 1990, Obstetrics and gynecology.
[9] I. Jansson,et al. Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: criteria to be used for ultrasound evaluation. , 1989, Gynecologic oncology.
[10] M Zelen,et al. Some pitfalls in the evaluation of screening programs. , 1969, Archives of environmental health.
[11] B. Hulka. Cancer screening degrees of proof and practical application , 1988, Cancer.
[12] Elizabeth A. Thompson,et al. Transvaginal sonography as a screening method for ovarian cancer a report of the first 1000 cases screened , 1990, Cancer.